• WVU Cancer Institute offering groundbreaking treatment for gastroenteropancreatic neuroendocrine tumors

    WVU Cancer Institute offering groundbreaking treatment for gastroenteropancreatic neuroendocrine tumors

    The WVU Cancer Institute is participating in the implementation of a new drug therapy for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), a type of tumor that can form in the pancreas or in other parts of the gastrointestinal tract, including the stomach, small intestine, colon, rectum, and appendix. These life-threatening tumors can spread to other organs, such as the liver.

    Read More

Patient Care